LATEST

• BUSINESS Ferring Nabs Japan Approval for Bladder Cancer Gene Therapy
  May 12, 2026

• BUSINESS Teijin to Offload Legacy Drug Portfolio as It Speeds Up Pivot to Rare Diseases
  May 12, 2026

• BUSINESS Keytruda Extends Run as Japan’s Best-Selling Drug in April: Encise
  May 12, 2026

• BUSINESS ASKA Taps Ex-AbbVie Japan Chief Feliciano as Outside Director
  May 12, 2026

• REGULATORY Daiichi Sankyo Wins Japan Approval for MMR Vaccine Mimrit
  May 12, 2026

• ACADEMIA Arava Safety Backup at Risk as Questran Supply Falters on Nitrosamine Issue
  May 11, 2026

• BUSINESS Daiichi Sankyo Cuts FY2025 Profit Outlook on ADC Supply Plan Review
  May 11, 2026

• BUSINESS Capricor Sues Nippon Shinyaku over US Rights to DMD Cell Therapy
  May 11, 2026

• BUSINESS FDA Delays Review of Leqembi Iqlik for Alzheimer’s Initiation Therapy
  May 11, 2026

• BUSINESS Kyorin, Susmed Start Pivotal Trial of Tinnitus Therapy App
  May 11, 2026

• BUSINESS Kyorin Begins Japan PIII Trial of Beova in Pediatric OAB
  May 11, 2026

• BUSINESS Kyowa Kirin Keeps Long-Term KPIs despite OX40 Setback, Ups 2026 Core Profit Outlook
  May 11, 2026

• BUSINESS Onychomycosis Drug Jublia Now Available in Germany: Kaken
  May 11, 2026

• BUSINESS Fujifilm Bags Japan Approval for Meniscus Regenerative Therapy
  May 11, 2026

• BUSINESS Takeda Logs Positive PII/III Results for TAK-881 in PID, Eyes FY2026 Filing
  May 11, 2026

• BUSINESS Kyowa Kirin to Consolidate Domestic Research Sites in Yokohama
  May 11, 2026

• BUSINESS Kissei Sublicenses Taiwan Rights for Rigel’s AML Drug to OEP
  May 11, 2026

• BUSINESS Japan Review Underway for Rhythm’s Acquired Hypothalamic Obesity Drug
  May 11, 2026

• BUSINESS Deciphera Portfolio Powers Ono to Record Sales as It Eyes Post-Opdivo Era
  May 11, 2026

• BUSINESS Daiichi Sankyo Healthcare to Raise Prices of OTC Drugs amid Inflation
  May 11, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »